Table 3. Multivariate analysis for overall survival of the whole cohort.

	Hazard Ratio	CI 95%	P	3-year OS	10-year OS
Age
< 60	1.00			59%	47%
≥60	1.20	0.77–1.88	0.4251	38%	26%
IPI
≤ 2	1.00			68%	56%
> 2	1.82	1.21–2.74	0.0041	32%	21%
Primary treatment response
NR/EXITUS	1.00			12%	11%
CR/PR	0.14	0.09–0.22	<0.0001	74%	57%
Histology
ALCL ALK positive	1.00			70%	56%
Others	2.78	1.68–4.59	<0.0001	43%	33%
Chemotherapy scheme
CHO(E)P	1.00			42%	28%
MACOP-B	1.00	0.57–1.76	0.9998	62%	50%
Intensified	0.78	0.46–1.34	0.3760	51%	45%
Year of treatment
≤ 2003	1.00			57%	44%
> 2003	0.77	0.48–1.25	0.2906	44%	-